Anti-GalNAc-GD1a Monoclonal Antibody (2A3D2)1vial

2,3-Dichloro-5-nitrobenzoic acid, 95+%, 100mg

Methyl 5-(3-fluorophenyl)isoxazole-3-carboxylate, 250mg

4-(3-Amino-1,2,4-triazin-6-yl)-2-fluorobenzonitrile, 95.0%, 1g

1-Iodo-2-nitro-4-(trifluoromethyl)benzene, 95.0%, 5g

4-Fluoro-2-(trifluoromethyl)benzoic acid, 97.0%, 25g

Boc-(R)-3-amino-3-(3-trifluoromethylphenyl)propionic acid, 99.0%, 250mg

2-Bromo-6-methylpyrazine, 95.0%, 250mg

Boc-N-Me-L-norvaline, 98.0%, 5g

L-Kynurenin, min. 98 %, für die Biochemie, 250 mg, Glasverpackung

Trimethylthiourea, 98.0%, 100g

tert-butyl (2S,4S)-4-amino-2-methyl-1-piperidinecarboxylate hydrochloride, 95.0%, 1g

4-BROMO-3-(DIFLUOROMETHYL)ANILINE, 95%, 100mg